Update shared on 30 Oct 2025
Encompass Health's analyst price target has been increased by $10 to $150. Analysts cite strong discharge growth and ongoing expansion strategies as key factors supporting the upward revision.
Analyst Commentary
Analyst sentiment following the price target raise for Encompass Health reflects both optimism and caution regarding the company's growth trajectory and valuation.
Bullish Takeaways
- Bullish analysts point to continued strong discharge growth as a key factor supporting the revised valuation.
- Execution of the de novo strategy, particularly targeting new markets with historically low conversion rates of acute care discharges to inpatient rehabilitation facilities (IRFs), is expected to drive further expansion.
- Ongoing efforts to improve conversion rates at existing hospitals could enhance overall operational efficiency and revenue growth.
- Plans to convert beds from semi-private to private are seen as a positive move. This change could potentially increase patient satisfaction and optimize hospital capacity.
Bearish Takeaways
- Some bearish analysts express concern about the challenges of sustaining strong discharge growth in a competitive healthcare environment.
- There are potential risks associated with the execution of new market entry strategies, particularly in regions with low historical conversion rates.
- Operational changes, such as converting beds from semi-private to private, could lead to increased costs and temporary disruptions during implementation.
What's in the News
- Opened the 25th Encompass Health Rehabilitation Hospital in Florida, located in St. Petersburg. The facility offers 50 private rooms and advanced rehabilitation services for patients recovering from various conditions (Key Developments).
- Launched the first Encompass Health facility in Connecticut, a 40-bed hospital in Danbury that provides comprehensive inpatient rehabilitation for conditions such as strokes and orthopedic injuries (Key Developments).
- Announced a joint venture with BSA Health System to operate a new 50-bed rehabilitation hospital in Amarillo, Texas. Opening is planned for late 2025 (Key Developments).
- Plans to construct a 50-bed inpatient rehabilitation hospital in Haslet, Texas, as part of ongoing national expansion efforts (Key Developments).
- Raised 2025 earnings guidance with higher net operating revenue expectations, reflecting improved business outlook (Key Developments).
Valuation Changes
- Fair Value Estimate remains unchanged at $139.08 per share.
- Discount Rate holds steady at 6.78%, indicating no change in risk assessment.
- Revenue Growth forecast has edged down fractionally to 8.14% from 8.14%.
- Net Profit Margin is virtually flat, moving marginally up to 9.93% from 9.92%.
- Future P/E Ratio estimate remains constant at 23.80x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.